SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Darren Hiu Kwong Lee, Poh-Yi Gan, Marina Katerelos, Scott Andrew Fraser, Kurt Gleich, Stephen Roger Holdsworth, David Anthony Power, Absence of the lysosomal protein Limp-2 attenuates renal injury in crescentic glomerulonephritis, Immunology and Cell Biology, 2014, 92, 5, 400

    CrossRef

  2. 2
    Evandro Mendes Klumb, Clovis Artur Almeida Silva, Cristina Costa Duarte Lanna, Emilia Inoue Sato, Eduardo Ferreira Borba Neto, João Carlos Tavares Brenol, Elisa Martins das Neves de Albuquerque, Odirlei Andre Monticielo, Lilian Tereza Lavras Costallat, Luiz Carlos Latorre, Maria de Fátima Lobato da Cunha Sauma, Eloisa Silva Dutra de Oliveira Bonfá, Francinne Machado Ribeiro, Consenso da Sociedade Brasileira de Reumatologia para o diagnóstico, manejo e tratamento da nefrite lúpica, Revista Brasileira de Reumatologia, 2014,

    CrossRef

  3. 3
    Elisheva Pokroy-Shapira, Ilana Gelernter, Yair Molad, Evolution of chronic kidney disease in patients with systemic lupus erythematosus over a long-period follow-up: a single-center inception cohort study, Clinical Rheumatology, 2014, 33, 5, 649

    CrossRef

  4. 4
    Nathalie Costedoat-Chalumeau, Bertrand Dunogué, Nathalie Morel, Véronique Le Guern, Gaëlle Guettrot-Imbert, Hydroxychloroquine: A multifaceted treatment in lupus, La Presse Médicale, 2014, 43, 6, e167

    CrossRef

  5. 5
    J. Weinmann-Menke, D. Sollinger, Immunsuppressive Therapie der Lupusnephritis, Der Nephrologe, 2014,

    CrossRef

  6. 6
    Guillermo Ruiz-Irastorza, Alvaro Danza, Isabel Perales, Irama Villar, Miriam Garcia, Sonia Delgado, Munther Khamashta, Prednisone in lupus nephritis: How much is enough?, Autoimmunity Reviews, 2014, 13, 2, 206

    CrossRef

  7. 7
    Veronica Rodriguez-Garcia, Sofia Sapeta Dias, David Isenberg, Recent advances in the treatment of systemic lupus erythematosus, International Journal of Clinical Rheumatology, 2014, 9, 1, 89

    CrossRef

  8. 8
    Satish Haridasan, Aman Sharma, Manish Rathi, Treatment of membranous lupus nephritis, Clinical Queries: Nephrology, 2014, 3, 2-4, 106

    CrossRef

  9. 9
    Tak Mao Chan, Treatment of severe lupus nephritis: the new horizon, Nature Reviews Nephrology, 2014, 11, 1, 46

    CrossRef

  10. 10
    Michael Bennett, Hermine I. Brunner, Biomarkers and Updates on Pediatrics Lupus Nephritis, Rheumatic Disease Clinics of North America, 2013, 39, 4, 833

    CrossRef

  11. 11
    Cristen B. Chafin, Nicole L. Regna, Sarah E. Hammond, Christopher M. Reilly, Cellular and urinary microRNA alterations in NZB/W mice with hydroxychloroquine or prednisone treatment, International Immunopharmacology, 2013, 17, 3, 894

    CrossRef

  12. 12
    Andrew F. Harron, Khoa Hoang, Charles N. McEwen, High mass resolution tissue imaging at atmospheric pressure using laserspray ionization mass spectrometry, International Journal of Mass Spectrometry, 2013, 352, 65

    CrossRef

  13. 13
    Laurence Beck, Andrew S. Bomback, Michael J. Choi, Larry B. Holzman, Carol Langford, Laura H. Mariani, Michael J. Somers, Howard Trachtman, Meryl Waldman, KDOQI US Commentary on the 2012 KDIGO Clinical Practice Guideline for Glomerulonephritis, American Journal of Kidney Diseases, 2013, 62, 3, 403

    CrossRef

  14. 14
    A. Pérez Gómez, L. Ruiz Gutiérrez, H. Moruno Cruz, F. Albarrán Hernández, Lupus eritematoso sistémico (II), Medicine - Programa de Formación Médica Continuada Acreditado, 2013, 11, 32, 1966

    CrossRef

  15. 15
    Nancy J. Olsen, Michele A. Schleich, David R. Karp, Multifaceted effects of hydroxychloroquine in human disease, Seminars in Arthritis and Rheumatism, 2013, 43, 2, 264

    CrossRef

  16. 16
    Anna Ewa Litwic, Melonie Kannamma Sriranganathan, Christopher John Edwards, Race and the response to therapies for lupus: how strong is the evidence?, International Journal of Clinical Rheumatology, 2013, 8, 4, 471

    CrossRef

  17. 17
    Shabina Habibi, Review of refractory lupus nephritis, International Journal of Clinical Rheumatology, 2013, 8, 1, 61

    CrossRef

  18. 18
    Guillermo Ruiz-Irastorza, Alvaro Danza, Munther Khamashta, Tratamiento del lupus eritematoso sistémico: mitos, certezas y dudas, Medicina Clínica, 2013, 141, 12, 533

    CrossRef

  19. 19
    Jonathan Hogan, Gerald B. Appel, Update on the treatment of lupus nephritis, Current Opinion in Nephrology and Hypertension, 2013, 22, 2, 224

    CrossRef

  20. 20
    Louise Watson, Michael W. Beresford, Urine biomarkers in juvenile-onset SLE nephritis, Pediatric Nephrology, 2013, 28, 3, 363

    CrossRef

  21. 21
    J. Antonio Aviña-Zubieta, John M. Esdaile, Dubois' Lupus Erythematosus and Related Syndromes, 2013,

    CrossRef

  22. 22
    A. Devlin, R. Ramsey-Goldman, K.H. Costenbader, Women and Health, 2013,

    CrossRef

  23. 23
    Adriana Migliorini, Hans-Joachim Anders, A novel pathogenetic concept—antiviral immunity in lupus nephritis, Nature Reviews Nephrology, 2012, 8, 3, 183

    CrossRef

  24. You have free access to this content24
    Bevra H. Hahn, Maureen A. McMahon, Alan Wilkinson, W. Dean Wallace, David I. Daikh, John D. FitzGerald, George A. Karpouzas, Joan T. Merrill, Daniel J. Wallace, Jinoos Yazdany, Rosalind Ramsey-Goldman, Karandeep Singh, Mazdak Khalighi, Soo-In Choi, Maneesh Gogia, Suzanne Kafaja, Mohammad Kamgar, Christine Lau, William J. Martin, Sefali Parikh, Justin Peng, Anjay Rastogi, Weiling Chen, Jennifer M. Grossman, American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis, Arthritis Care & Research, 2012, 64, 6
  25. 25
    G. J. Pons-Estel, G. S. Alarcon, L. Hachuel, G. Boggio, D. Wojdyla, V. Pascual-Ramos, E. R. Soriano, V. Saurit, F. S. Cavalcanti, R. A. Guzman, M. Guibert-Toledano, M. J. Sauza del Pozo, M.-C. Amigo, M. Alva, M. H. Esteva-Spinetti, B. A. Pons-Estel, Anti-malarials exert a protective effect while Mestizo patients are at increased risk of developing SLE renal disease: data from a Latin-American cohort, Rheumatology, 2012, 51, 7, 1293

    CrossRef

  26. 26
    Chapter 12: Lupus nephritis, Kidney International Supplements, 2012, 2, 2, 221

    CrossRef

  27. 27
    G. Ruiz-Irastorza, G. Espinosa, M.A. Frutos, J. Jiménez Alonso, M. Praga, L. Pallarés, F. Rivera, Á. Robles Marhuenda, A. Segarra, C. Quereda, Diagnóstico y tratamiento de la nefritis lúpica, Revista Clínica Española, 2012, 212, 3, 147.e1

    CrossRef

  28. 28
    Anne V. Miller, Sriya K.M. Ranatunga, Immunotherapies in Rheumatologic Disorders, Medical Clinics of North America, 2012, 96, 3, 475

    CrossRef

  29. 29
    Andrea T. Borchers, Naama Leibushor, Stanley M. Naguwa, Gurtej S. Cheema, Yehuda Shoenfeld, M. Eric Gershwin, Lupus nephritis: A critical review, Autoimmunity Reviews, 2012, 12, 2, 174

    CrossRef

  30. 30
    Onkar P. Kulkarni, Hans-Joachim Anders, Lupus nephritis. How latest insights into its pathogenesis promote novel therapies, Current Opinion in Rheumatology, 2012, 24, 5, 457

    CrossRef

  31. 31
    M. Haubitz, Lupusnephritis, Zeitschrift für Rheumatologie, 2012, 71, 10, 875

    CrossRef

  32. 32
    M. Haubitz, Lupusnephritis, Der Nephrologe, 2012, 7, 1, 63

    CrossRef

  33. 33
    Daniel J. Wallace, Vineet S. Gudsoorkar, Michael H. Weisman, Swamy R. Venuturupalli, New insights into mechanisms of therapeutic effects of antimalarial agents in SLE, Nature Reviews Rheumatology, 2012, 8, 9, 522

    CrossRef

  34. 34
    I. G. Okpechi, O. E. Ayodele, E. S. W. Jones, M. Duffield, C. R. Swanepoel, Outcome of patients with membranous lupus nephritis in Cape Town South Africa, Nephrology Dialysis Transplantation, 2012, 27, 9, 3509

    CrossRef

  35. 35
    Antonis Fanouriakis, Eleni Krasoudaki, Michail Tzanakakis, Dimitrios T. Boumpas, Recent progress in the treatment of lupus nephritis, Modern Rheumatology, 2012, 22, 6, 803

    CrossRef

  36. 36
    Antonis Fanouriakis, Eleni Krasoudaki, Michail Tzanakakis, Dimitrios T. Boumpas, Recent progress in the treatment of lupus nephritis, Modern Rheumatology, 2012, 22, 6, 803

    CrossRef

  37. 37
    Guillermo J. Pons-Estel, Rosa Serrano, Miguel A. Plasín, Gerard Espinosa, Ricard Cervera, Epidemiology and management of refractory lupus nephritis, Autoimmunity Reviews, 2011, 10, 11, 655

    CrossRef

  38. 38
    Crispin Abarientos, Kirk Sperber, Deborah L Shapiro, Wilbert S Aronow, Chun Peng Chao, Julia Y Ash, Hydroxychloroquine in systemic lupus erythematosus and rheumatoid arthritis and its safety in pregnancy, Expert Opinion on Drug Safety, 2011, 10, 5, 705

    CrossRef

  39. 39
    Graciela S. Alarcón, Multiethnic lupus cohorts: What have they taught us?, Reumatología Clínica, 2011, 7, 1, 3

    CrossRef

  40. 40
    Senq-J Lee, Earl Silverman, Joanne M. Bargman, The role of antimalarial agents in the treatment of SLE and lupus nephritis, Nature Reviews Nephrology, 2011, 7, 12, 718

    CrossRef

  41. 41
    Brad H. Rovin, Isaac E. Stillman, Systemic Lupus Erythematosus, 2011,

    CrossRef

  42. 42
    Nathalie Costedoat-Chalumeau, Gaëlle Leroux, Jean-Charles Piette, Zahir Amoura, Systemic Lupus Erythematosus, 2011,

    CrossRef

  43. 43
    Earl Silverman, Allison Eddy, Textbook of Pediatric Rheumatology, 2011,

    CrossRef

  44. 44
    Jose-Luis Ayensa, Munther Khamashta, Guillermo Ruiz-Irastorza, A new role for antimalarials in systemic lupus erythematosus treatment, International Journal of Clinical Rheumatology, 2010, 5, 3, 299

    CrossRef

  45. 45
    Samuel K. Shinjo, Eloísa Bonfá, Daniel Wojdyla, Eduardo F. Borba, Luis A. Ramirez, Hugo R. Scherbarth, João C. Tavares Brenol, Rosa Chacón-Diaz, Oscar J. Neira, Guillermo A. Berbotto, Ignacio Garcia de la Torre, Eduardo M. Acevedo-Vázquez, Loreto Massardo, Leonor A. Barile-Fabris, Francisco Caeiro, Luis H. Silveira, Emilia I. Sato, Sandra Buliubasich, Graciela S. Alarcón, Bernardo A. Pons-Estel, Antimalarial treatment may have a time-dependent effect on lupus survival: Data from a multinational Latin American inception cohort, Arthritis & Rheumatism, 2010, 62, 3
  46. 46
    Liz Lightstone, Lupus nephritis: where are we now?, Current Opinion in Rheumatology, 2010, 22, 3, 252

    CrossRef

  47. 47
    Stephen D Marks, Kjell Tullus, Modern therapeutic strategies for paediatric systemic lupus erythematosus and lupus nephritis, Acta Paediatrica, 2010, 99, 7
  48. 48
    Thomas Dörner, Therapy: Hydroxychloroquine in SLE: old drug, new perspectives, Nature Reviews Rheumatology, 2010, 6, 1, 10

    CrossRef

  49. 49
    Evelyne Vinet, Sasha Bernatsky, Samy Suissa, Have some beneficial effects of hydroxychloroquine been overestimated? Potential biases in observational studies of drug effects: Comment on the article by Pons-Estel et al, Arthritis Care & Research, 2009, 61, 11
  50. 50
    Steven C. Vlad, Protective effect of hydroxychloroquine on renal damage may be biased: Comment on the article by Pons-Estel et al, Arthritis Care & Research, 2009, 61, 11
  51. 51
    Paula I. Burgos, Elizabeth L. Perkins, Guillermo J. Pons-Estel, Scott A. Kendrick, Jigna M. Liu, William T. Kendrick, William J. Cook, Bruce A. Julian, Graciela S. Alarcón, Clifton E. Kew, Risk factors and impact of recurrent lupus nephritis in patients with systemic lupus erythematosus undergoing renal transplantation: Data from a single US institution, Arthritis & Rheumatism, 2009, 60, 9
  52. 52
    Graciela S Alarcón, Risk factors for thrombotic events in patients with systemic lupus erythematosus from different ethnic groups, International Journal of Clinical Rheumatology, 2009, 4, 3, 267

    CrossRef

  53. 53
    Paula I Burgos, Graciela S Alarcón, Thrombosis in systemic lupus erythematosus: risk and protection, Expert Review of Cardiovascular Therapy, 2009, 7, 12, 1541

    CrossRef